Senti Biosciences Holdings (SNTI) EBIT Margin (QoQ) (2021 - 2023)
Powered by 
Analysis
Senti Biosciences Holdings (SNTI) EBIT Margin (QoQ) (2021 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.23 Bn | 9.38 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.05 Bn | 5.05 Bn | - |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.59 Bn | 2.63 Bn | 251.50 Mn |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.22 Bn | 1.42 Bn | 251.87 Mn |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn |
| 10 | Senti Biosciences Holdings | 9.47 Mn | 9.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | -1.14 Mn |
| Jun 30, 2023 | -45,731.00 |
| Mar 31, 2023 | 2.73 Mn |
| Dec 31, 2022 | -2.76 Mn |
| Sep 30, 2022 | 76,806.00 |
| Jun 30, 2022 | -53,813.00 |
| Mar 31, 2022 | -57,754.00 |
| Dec 31, 2021 | 54,813.00 |
| Sep 30, 2021 | 9,880.00 |